These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Does a Change in Device Design Alter Device Size Selection? A Comparison of Conventional and Occlutech Duct Occluder Designs. Subramanian A, Paraswanath BA, Govind Auradkar, Mahimarangaiah J. Heart Lung Circ; 2022 Dec; 31(12):1677-1684. PubMed ID: 36089464 [Abstract] [Full Text] [Related]
8. Closure of very large PDA with pulmonary hypertension: Initial clinical case-series with the new Occlutech® PDA occluder. Lehner A, Ulrich S, Happel CM, Fischer M, Kantzis M, Schulze-Neick I, Haas NA. Catheter Cardiovasc Interv; 2017 Mar 01; 89(4):718-725. PubMed ID: 27860161 [Abstract] [Full Text] [Related]
10. Closure of the patent ductus arteriosus with the Amplatzer Duct Occluder II: a clinical experience. Karagöz T, Akin A, Ertuğrul I, Aykan HH, Alehan D, Ozer S, Ozkutlu S. Acta Cardiol; 2012 Dec 01; 67(6):675-80. PubMed ID: 23393938 [Abstract] [Full Text] [Related]
11. Transcatheter closure of patent ductus arteriosus using the AMPLATZER™ duct occluder II (ADO II). Gruenstein DH, Ebeid M, Radtke W, Moore P, Holzer R, Justino H. Catheter Cardiovasc Interv; 2017 May 01; 89(6):1118-1128. PubMed ID: 28258658 [Abstract] [Full Text] [Related]
16. Percutaneous closure of the patent ductus arteriosus using the Nit-Occlud PDA-R (reverse) device: initial experience reporting immediate and short-term results. Peirone A, Diaz J, Contreras A, Banille E, Cabrera M, Spillmann A, Bueno N, Juaneda E. J Invasive Cardiol; 2011 Dec 01; 23(12):513-6. PubMed ID: 22147399 [Abstract] [Full Text] [Related]